Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
Journal of Psychopharmacology (Oxford, England)|December 21, 2020
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysisBenjamin Jg Illingworth, Declan J Lewis, Andrew T Lambarth, et al.American Journal of Respiratory and Critical Care Medicine|April 8, 1999
Isocapnic hyperpnea accelerates carbon monoxide eliminationJ A Fisher, J Rucker, L Z Sommer, et al.Journal of Psychopharmacology (Oxford, England)|June 8, 2022
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)Emma I Kopra, Jason A Ferris, James J Rucker, et al.Journal of Clinical Pharmacology|September 2, 2021
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis RegistryMichal Kawka, Simon Erridge, Carl Holvey, et al.Brain and Behavior|April 7, 2026
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for MigraineLennon Hooper, Simon Erridge, Evonne Clarke, et al.The European Respiratory Journal|October 8, 1998
A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoeaL Z Sommer, S Iscoe, A Robicsek, et al.Expert Review of Gastroenterology & Hepatology|December 23, 2022
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis RegistryNishaanth Dalavaye, Simon Erridge, Martha Nicholas, et al.Translational Psychiatry|April 24, 2026
Characterising the clinical associations of hallucinogen persisting perception disorder: a retrospective cohort studyMatt Butler, Ellen Moore, James J Rucker, et al.Alimentary Pharmacology & Therapeutics|August 22, 2006
Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteersN J Talley, M Camilleri, D Burton, et al.Journal of Psychopharmacology (Oxford, England)|August 30, 2025
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialNiall M McGowan, James J Rucker, Rachel Yehuda, et al.Pageof 12